share_log

Spero Therapeutics | 8-K: Spero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business Update

SEC ·  Aug 10, 2023 16:17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more